on 19 Nov 2024
Last Applicant/ Owned by
Emil-von-Behring Str. 76
Marburg
DE
D-35041
Serial Number
97779170 filed on 03rd Feb 2023
Registration Number
7568163 registered on 19th Nov 2024
Correspondent Address
Scott D. Woldow
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema,fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasmafractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment andprevention of blood and blee Read More
Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema,fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasmafractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment andprevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparationsfor the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment ofhemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia;blood products for the treatment of hemophilia, namely, a blood clotting aid and delivery system for use in human and veterinarymedicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodies, namely, diagnostic kitsconsisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; blood for medical purposes; cellcultures for medical purposes, namely, cells for medical or clinical use; cell cultures for medical purposes, namely, living cells formedical use; cell cultures for medical purposes, namely, stem cells for medical or veterinary use; pharmaceutical preparations forthe treatment of blood conditions, respiratory conditions, pneumonia, covid-19, and influenza; Pharmaceutical preparations,namely, antibody for the treatment of acute respiratory distress syndrome, ARDS; pharmaceutical preparations, namely, antibodyfor the treatment of Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; Pharmaceutical preparations, namely,antibody for the treatment of Hereditary Angioedema, HAE; Pharmaceutical preparations, namely, for the treatment of HereditaryAngioedema, HAE, respiratory diseases, acute respiratory distress syndrome, ARDS, Idiopathic Pulmonary Fibrosis, IPF andInterstitial Lung Diseases, ILD
N/A
N/A
No 97779170
No Service/Collective Mark
No 034845.375
Yes
No
No
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
19th Nov 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
19th Nov 2024 | REGISTERED-PRINCIPAL REGISTER |
03rd Sep 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
03rd Sep 2024 | PUBLISHED FOR OPPOSITION |
14th Aug 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
29th Jul 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
16th Jul 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
16th Jul 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
15th Jul 2024 | ASSIGNED TO LIE |
25th Jan 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |